BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Han QY, Liu ZW. Current treatment of chronic hepatitis C in China: Dilemma and potential problems. World J Gastroenterol 2016; 22(19): 4615-4618 [PMID: 27217693 DOI: 10.3748/wjg.v22.i19.4615]
URL: https://www.wjgnet.com/1948-5182/full/v22/i19/4615.htm
Number Citing Articles
1
Shu Su, Christopher K. Fairley, Joe Sasadeusz, Jianmei He, Xiuqing Wei, Huan Zeng, Jun Jing, Limin Mao, Xi Chen, Lei Zhang. HBV, HCV, and HBV/HCV co-infection among HIV-positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcomeJournal of Medical Virology 2018; 90(3): 518 doi: 10.1002/jmv.24988
2
Erica Godinho Menezes, Jordana Grazziela Alves Coelho-dos-Reis, Ludmila Melo Cardoso, Ágata Lopes-Ribeiro, Juan Jonathan-Gonçalves, Marco Túlio Porto Gonçalves, Rodrigo Dias Cambraia, Eric Bassetti Soares, Luciana Diniz Silva, Vanessa Peruhype-Magalhães, Maria Rios, Caren Chancey, Andréa Teixeira-Carvalho, Olindo Assis Martins-Filho, Rosângela Teixeira. Strategies for serum chemokine/cytokine assessment as biomarkers of therapeutic response in HCV patients as a prototype to monitor immunotherapy of infectious diseasesAntiviral Research 2017; 141: 19 doi: 10.1016/j.antiviral.2017.02.001
3
Wen Chen, Thomas Ward, Mai Ping Tan, Jing Yan, Peter Feng Wang, Gail D Wygant, Jason Gordon. Daclatasvir combined with asunaprevir is a cost-effective and cost-saving treatment for hepatitis C infection in ChinaJournal of Comparative Effectiveness Research 2018; 7(8): 785 doi: 10.2217/cer-2018-0005
4
Shiyu Cao, Fuqiang Liu, Tingting Wang, Yaqing Tan, Shujun Liu, Yuan Liu, Lidong Gao, Lizhang Chen. New patterns emerge after a sustained increase in the incidence of hepatitis C virus infection from 2004 to 2017: a joinpoint regression analysisPublic Health 2019; 170: 49 doi: 10.1016/j.puhe.2019.01.014
5
Jian-Hong Chen, Zheng Zeng, Xia-Xia Zhang, Yu Zhang, Ren-Wen Zhang, Shuai Wang, Chi-Hong Wu, Min Yu, Dan Liu, Hong-Li Xi, Yi-Xing Zhou, Yao-Yu An, Xiao-Yuan Xu. Efficacy and safety of combined directly acting antivirals for treatment of Chinese chronic hepatitis C patients in a real-world settingWorld Journal of Gastroenterology 2017; 23(22): 4072-4079 doi: 10.3748/wjg.v23.i22.4072
6
Zobair M Younossi, Maria Stepanova, Tarik Asselah, Graham Foster, Keyur Patel, Norbert Bräu, Mark Swain, Tram Tran, Rafael Esteban, Massimo Colombo, Stephen Pianko, Linda Henry, Marc Bourliere. Hepatitis C in Patients With Minimal or No Hepatic Fibrosis: The Impact of Treatment and Sustained Virologic Response on Patient-Reported OutcomesClinical Infectious Diseases 2018; 66(11): 1742 doi: 10.1093/cid/cix1106
7
Jinyu Liu, Yu Zhang, Bin Wu, Sen Wang, David Bin-Chia Wu, Ruxu You. Cost-Effectiveness of Testing for NS5A Resistance to Optimize Treatment of Elbasvir/Grazoprevir for Chronic Hepatitis C in ChinaFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.717504